Levonorgestrel capsule implants in the United States: A 5-year study

Obstetrics and Gynecology

Volumn 92, Issue 3, 1998, Pages 337-344

  Sivin, Irving ^a   Mishell Jr, D R ^b   Darney, Philip ^c   Wan, Livia ^d   Christ, Mercedes ^e  

^a POPULATION COUNCIL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

ADULT; ARTICLE; DRUG EFFICACY; DRUG FORMULATION; ECTOPIC PREGNANCY; FEMALE; HEADACHE; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; PREGNANCY RATE; PRIORITY JOURNAL; REGRESSION ANALYSIS; WEIGHT GAIN;

ADULT; CAPSULES; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; HUMANS; LEVONORGESTREL; PREGNANCY; PROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES;

EID: 0031678826     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00219-1     Document Type: Article

References (27)

1. Sivin I. International experience with Norplant and Norplant 2 contraceptives. Stud Fam Plann. 19:1988;81-94.
2. World Health Organization. International monitoring of adverse reactions to drugs: Adverse Reaction Terminology (WHOART). 31 Dec 1991.
3. Population Council. NDA 19-897 1989;vol. 2.1.
4. Mishell D.R. Jr. Editorial note. Contraception. 55:1997;319-320.
5. Speroff L., Darney P. A clinical guide to contraception. 1996;158-160 Williams and Wilkins, Baltimore.
6. Diaz S., Pavez M., Miranda P., Robertson D.N., Sivin I., Croxatto H.B. A five year clinical trial of levonorgestrel silastic implants. Contraception. 25:1982;447-456.
7. Gu S.-J., Du M.-K., Zhang L.-D., Liu Y.-L., Wang S.-H., Sivin I. A 5-year evaluation of Norplant contraceptive implants in China. Obstet Gynecol. 83:1994;673-678.
8. Grubb G., Moore D., Anderson N.G. Pre-introductory clinical trials of Norplant implants A comparison of 17 countries' experience . Contraception. 52:1995;287-296.
9. Peterson H.B., Xia Z., Hughes J.M., Wilcox L.S., Tylor L.R., Trussell J. The risk of pregnancy after tubal sterilization Findings from the U.S. Collaborative Review of Sterilization . Am J Obstet Gynecol. 174:1996;1161-1170.
10. Franks A.L., Beral V., Cates W. Jr, Hogue C.J.R. Contraception and ectopic pregnancy risk. Am Obstet Gynecol. 163:1990;1120-1123.
11. Sivin I. Alternative estimates of ectopic pregnancy risks during contraception. Am J Obstet Gynecol. 165:1991;1899-1900.
12. Crosby U.D., Schwarz B.E., Gluck K.L., Heartwell S.F. A preliminary report of Norplant implant insertions in a large urban family planning program. Contraception. 48:1993;359-366.
13. Polaneczky M., Slap G., Forke C., Rappaport A., Sondheimer S. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers. N Engl J Med. 331:1994;1201-1206.
14. Berenson A.B., Wiemann C.M., Rickert V.I., McCombs S.L. Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use. Am J Obstet Gynecol. 176:1997;586-592.
15. Blumenthal P.D., Wilson L.E., Remsburg R.E., Cullins V.E., Huggins G.R. Contraceptive outcomes among postpartum and postabortal adolescents. Contraception. 50:1994;451-460.
16. Cullins V.E., Blumenthal P.D., Remsburg R.E., Huggins G.R. Preliminary experience with Norplant in an inner city population. Contraception. 47:1993;193-204.
17. Gerber S., Westhoff C., Lopez M., Gordon L. Use of Norplant implants in a New York City clinic population. Contraception. 49:1994;557-564.
18. Rosenthal S.L., Biro F.M., Kollar L.M., Hillard P.J.A., Rauh J.L. Experience with side effects and health risks associated with Norplant implant use in adolescents. Contraception. 52:1995;283-285.
19. Haugen M.M., Evans C.B., Kim M.H. Patient satisfaction with a levonorgestrel-releasing contraceptive implant Reasons for and patterns of removal . J Reprod Med. 41:1996;849-854.
20. Kozlowski K.J., Rickert V.I., Hendon A., Davis P. Adolescents and Norplant Preliminary findings of side effects . J Adolesc Health. 16:1995;373-378.
21. Dugoff L., Jones O.W. III, Allen-Davis J., Hurst B.S., Schlaff W.D. Assessing the acceptability of Norplant contraceptive in four patient populations. Contraception. 52:1995;45-49.
22. Frank M.L., Poindexter A.N. III, Cornin L.M., Cox C.A., Bateman L. One year experience with subdermal contraceptive implants in the United States. Contraception. 48:1993;229-249.
23. Dinerman L.M., Wilson M.D., Duggan A.K., Joffe A. Outcomes of adolescents using levonorgestrel implants vs oral contraceptives or other contraceptive methods. Arch Pediatr Adolesc Med. 149:1995;967-972.
24. Ricketts SA. Repeat fertility and contraceptive implant use among Medicaid recipients in Colorado. Fam Plann Perspect 1996;28:278-80,284.
25. Sivin I. Norplant contraceptive implants. Shoupe D., Haseltine F.P. Contraception. 1992;131-142 Springer Verlag, New York.
26. Biswas A., Viegas O.A.C., Leong W.P., Singh K., Ratnam S.S. A five year analysis of menstrual bleeding patterns in Norplant users. Br J Fam Plann. 21:(Suppl):1995;11-13.
27. Biswas A., Leong W.P., Ratnam S.S., Viegas O.A.C. Menstrual bleeding patterns in Norplant 2 implant users. Contraception. 54:1996;91-95.